erucin has been researched along with Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantelli-Forti, G; D'Amico, M; Djemil, A; Hrelia, P; Morroni, F; Pruccoli, L; Sita, G; Tarozzi, A | 1 |
Bolondi, C; Cantelli-Forti, G; Djemil, A; Hrelia, P; Morroni, F; Sita, G; Tarozzi, A | 1 |
2 other study(ies) available for erucin and Parkinson Disease
Article | Year |
---|---|
Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease.
Topics: Animals; Brassica; Cell Line, Tumor; Dopaminergic Neurons; Glutathione; Humans; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; Neuroblastoma; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidopamine; Parkinson Disease; RNA, Messenger; Sulfides; Sulfoxides; Thiocyanates | 2018 |
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.
Topics: Adrenergic Agents; Antioxidants; Cell Death; Cell Line, Tumor; Dopaminergic Neurons; Glutathione; Humans; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Reactive Oxygen Species; Sulfides; Thiocyanates | 2012 |